Header Logo

Connection

ANNA MALOVANNAYA to Pyrazoles

Back to Details
This is a "connection" page, showing publications ANNA MALOVANNAYA has written about Pyrazoles.
ANNA MALOVANNAYA
Connection Strength
0.051
Pyrazoles
  1. Preclinical efficacy of CDK7 inhibitor-based combinations against myeloproliferative neoplasms transformed to AML. Blood. 2025 Feb 06; 145(6):612-624.
    View in: PubMed
    Score: 0.051
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.